chr6-90516567-G-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_145331.3(MAP3K7):c.1755C>T(p.Tyr585Tyr) variant causes a synonymous change. The variant allele was found at a frequency of 0.000422 in 1,612,578 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.0022 ( 2 hom., cov: 32)
Exomes 𝑓: 0.00023 ( 0 hom. )
Consequence
MAP3K7
NM_145331.3 synonymous
NM_145331.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 3.64
Genes affected
MAP3K7 (HGNC:6859): (mitogen-activated protein kinase kinase kinase 7) The protein encoded by this gene is a member of the serine/threonine protein kinase family. This kinase mediates the signaling transduction induced by TGF beta and morphogenetic protein (BMP), and controls a variety of cell functions including transcription regulation and apoptosis. In response to IL-1, this protein forms a kinase complex including TRAF6, MAP3K7P1/TAB1 and MAP3K7P2/TAB2; this complex is required for the activation of nuclear factor kappa B. This kinase can also activate MAPK8/JNK, MAP2K4/MKK4, and thus plays a role in the cell response to environmental stresses. Four alternatively spliced transcript variants encoding distinct isoforms have been reported. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -10 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.52).
BP6
Variant 6-90516567-G-A is Benign according to our data. Variant chr6-90516567-G-A is described in ClinVar as [Benign]. Clinvar id is 729099.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High AC in GnomAd4 at 340 AD gene.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00221 AC: 335AN: 151872Hom.: 2 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
335
AN:
151872
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000591 AC: 148AN: 250568 AF XY: 0.000391 show subpopulations
GnomAD2 exomes
AF:
AC:
148
AN:
250568
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000233 AC: 340AN: 1460588Hom.: 0 Cov.: 31 AF XY: 0.000189 AC XY: 137AN XY: 726600 show subpopulations
GnomAD4 exome
AF:
AC:
340
AN:
1460588
Hom.:
Cov.:
31
AF XY:
AC XY:
137
AN XY:
726600
Gnomad4 AFR exome
AF:
AC:
187
AN:
33362
Gnomad4 AMR exome
AF:
AC:
62
AN:
44632
Gnomad4 ASJ exome
AF:
AC:
0
AN:
26070
Gnomad4 EAS exome
AF:
AC:
0
AN:
39666
Gnomad4 SAS exome
AF:
AC:
0
AN:
86164
Gnomad4 FIN exome
AF:
AC:
0
AN:
53398
Gnomad4 NFE exome
AF:
AC:
40
AN:
1111224
Gnomad4 Remaining exome
AF:
AC:
47
AN:
60314
Heterozygous variant carriers
0
19
39
58
78
97
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00224 AC: 340AN: 151990Hom.: 2 Cov.: 32 AF XY: 0.00215 AC XY: 160AN XY: 74340 show subpopulations
GnomAD4 genome
AF:
AC:
340
AN:
151990
Hom.:
Cov.:
32
AF XY:
AC XY:
160
AN XY:
74340
Gnomad4 AFR
AF:
AC:
0.00681895
AN:
0.00681895
Gnomad4 AMR
AF:
AC:
0.00308601
AN:
0.00308601
Gnomad4 ASJ
AF:
AC:
0
AN:
0
Gnomad4 EAS
AF:
AC:
0
AN:
0
Gnomad4 SAS
AF:
AC:
0
AN:
0
Gnomad4 FIN
AF:
AC:
0
AN:
0
Gnomad4 NFE
AF:
AC:
0.0000589206
AN:
0.0000589206
Gnomad4 OTH
AF:
AC:
0.002849
AN:
0.002849
Heterozygous variant carriers
0
18
36
54
72
90
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=98/2
polymorphism
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at